Products

Private Capital Solutions

Addressing the capital requirements of businesses seeking to fund their growth, our team takes a comprehensive view of financing requirements to deliver custom solutions to capital structure issues

We provide bespoke solutions across a wide ranging product spectrum. Proceeds are most typically used for acquisition finance, growth capital, recapitalizations, and shareholder liquidity.

  • Revolving Credit Facility (RCF)
  • 1st-lien, 2nd-lien, and unitranche term loans
  • Private placements
  • Mezzanine debt
  • Venture debt
  • Hybrid capital/preferred equity/non-control equity

Our experienced team of professionals provides high-touch attention to deliver innovative, capital-efficient strategies that are fully integrated with our clients’ goals. Our approach is backed by the extensive resources of Cowen’s full-service banking platform to support client objectives across all stages of growth.

Our experienced team of professionals provides high-touch attention to deliver innovative, capital-efficient strategies that are fully integrated with our clients’ goals. Our approach is backed by the extensive resources of Cowen’s full-service banking platform to support client objectives across all stages of growth.

 

LEARN MORE ABOUT CROSS-ASSET

LEARN MORE ABOUT OUR INVESTMENT BANKING EXPERTISE

Latest Transactions

  • Megatronics Acquisition Corp., a newly formed entity comprised of the legacy Bestronics and DataED companies, will primarily engage in (i) the manufacturing of power supplies and assembly of surface mount and through hole electronic circuit boards (through DataED), and (ii) electronic manufacturing services related to printed circuit board assembly and testing for original equipment manufacturers in a variety of markets, including wireless data communications, biotechnology, environmental, pharmaceutical, medical instrumentation, and power switching industries (through Bestronics).
  • Turning Point Brands is a leading provider of non cigarette Other Tobacco Products and adult consumer alternatives.
  • Horizon Pharma USA, Inc. is focused on researching, developing and commercializing innovative medicines that address unmet treatment needs for rare and rheumatic diseases.

Team